Key result
Late normal pregnancy (third trimester) increased mean flow mediated dilatation by 80% and 64% compared to the first and second trimesters, and by 92% compared to non-pregnant controls (P<0.01).
Why the study?
Does normal human pregnancy improve endothelial cell function compared to non-pregnant controls?
Observational
Does normal human pregnancy improve endothelial cell function compared to non-pregnant controls?
p-value: p=<0.01
Endothelial cell function, as measured by flow mediated dilatation, is significantly enhanced during the third trimester of normal human pregnancy.
No takes yet. Share an insight, caveat, or question.
Third-trimester endothelial enhancement should not yet change practice; leaves open causality and relevance to complications.
Faber‐Swensson et al. (2004) conducted an observational in Normal human pregnancy. Third trimester of pregnancy vs. First and second trimesters, and non-pregnant controls was evaluated on Flow mediated dilatation (FMD) (p=<0.01). Late normal pregnancy (third trimester) increased mean flow mediated dilatation by 80% and 64% compared to the first and second trimesters, and by 92% compared to non-pregnant controls (P<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: